Maged Shenouda
Chief Financial Officer · RELMADA THERAPEUTICS, INC.
- 2025
- Sep 11, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Maged Shenouda files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Sergio Traversa - $1.54M in RLMD purchases and sales in the last 12 months
- Chuck Ence - $299K in RLMD purchases and sales in the last 12 months
- Paul Edward Kelly - $198K in RLMD purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Maged Shenouda?
Maged Shenouda is a corporate insider, tracked as Chief Financial Officer of RELMADA THERAPEUTICS, INC. (RLMD). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Maged Shenouda submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Maged Shenouda been buying or selling stock?
Recorded transactions: 4 open-market purchases ($1.99M) and 0 open-market sales across all tracked filings.
